Glucagon receptor activation is believed to increase energy expenditure and may potentially support hepatic fat reduction, though these latter effects remain under investigation and have not yet been fully characterised in humans
The maker of Wegovy is threatening to sue and take regulatory action, saying Hims & Hers' new weight loss medication is illegal and calling it an "unapproved, inauthentic and untested knockoff semaglutide pill." "The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety
Patients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonist
Still, the broader trend toward earlier initiation reflects a larger paradigm shift in diabetes care, where patients increasingly benefit from the use of GLP-1s early in their treatment journey
Retain it in the original sealed packaging until required for controlled laboratory evaluation
Review the dosing selection guide for personalized recommendations
